Lead the identification, development, and application of innovative statistical methodologies for clinical development programs.
Provide expert statistical consultation and shape statistical strategies for clinical trial design and analysis.
Mentor statisticians and build a statistical innovation team to foster methodological excellence.
Alnylam is the leader in RNAi therapeutics, a revolutionary approach with the potential to transform the lives of people with rare and common diseases. The company is a globally recognized top employer with an authentic, inclusive culture and a deep pipeline, late-stage programs, and a bold vision.
Lead biostatistics activities across clinical studies, ensuring high-quality analyses and clear communication.
Provide statistical expertise for oncology trials, from protocol development to regulatory submissions.
Oversee statistical programming and deliverables, ensuring quality, integrity, and compliance.
Jobgether is a platform that uses AI-powered matching to connect candidates with hiring companies, focusing on objective and fair application reviews. The company is dynamic and emphasizes a streamlined hiring process, with a data-driven approach and a commitment to innovation.
Serve as primary point-of-contact liaison with clients, providing outstanding customer service and participating in proposal activities and client presentations.
Oversee all aspects of clinical research trials, directing project managers and ensuring consistency across assigned portfolios.
Manage study budgets, financial health, and project plans, including risk management and quality assurance, while leading cross-functional teams.
Precision Medicine Group is a people-focused CRO that combines novel clinical trial designs, industry-leading operational and medical authorities, and advanced biomarker and data analytics solutions, with a passion for rare diseases and oncology. The company fosters a supportive and collaborative environment, promoting work-life balance and team development, with a growing team dedicated to ground-breaking cancer therapies.
Oversee global clinical trial execution, including site selection, activation, enrollment, and closeout, while ensuring compliance with GCP and regulatory requirements.
Partner with CROs to drive robust trial management, data monitoring, and patient enrollment strategies, and review study-related plans and documents.
Mentor and guide clinical operations team members, track performance metrics, and ensure inspection readiness across all study phases.
Summit Therapeutics is a biopharmaceutical oncology company focused on improving quality of life and resolving unmet medical needs through innovative clinical studies. With multiple global Phase 3 trials and offices across the US, UK, and Ireland, the company is committed to a collaborative, people-driven culture.
Provides strategic and scientific leadership for patient-centered outcomes engagements, ensuring research design and evidence packages are fit-for-purpose.
Owns client relationships, drives business development, and leads proposal development to achieve revenue and sales targets.
Oversees clinical outcome assessment projects including literature reviews, gap analyses, regulatory strategy, and dossier development.
Lumanity is a global strategic partner that brings together strategy, evidence, engagement, and technology to improve health outcomes. The company is dedicated to accelerating and optimizing access to life-changing medicines.
Act as primary point of contact for selected HCPs, providing disease education and scientific support in assigned territory.
Combine scientific engagement and non-promotional market access to improve patient care across the portfolio.
Organize local educational events, facilitate peer-to-peer exchange, and co-create account plans with cross-functional teams.
Ultragenyx is a biopharmaceutical company dedicated to developing life-changing treatments for rare diseases. They are committed to a supportive culture of learning and growth, with a global team focused on innovative approaches to patient care.
Lead and manage internal chemistry resources and CRO teams to identify IND-ready candidate molecules.
Serve as chemistry leader within multidisciplinary project teams, building effective relationships across geographically dispersed collaborators.
Use SAR analysis and computational tools to design novel molecules and establish intellectual property.
Centessa Pharmaceuticals is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Headquartered in Boston, Massachusetts, it was recognized as a Great Place to Work in 2026.
Establish and maintain relationships with investigators, sites, and key opinion leaders to support trial execution.
Gather site feedback and translate it into actionable improvements for study teams.
Contribute to protocol development, site selection, and business development activities.
This role is with a partner company that focuses on clinical research and trial execution. The company operates remotely and values collaboration, inclusion, and professional autonomy.
Lead clinical trial strategies and evidence-generation plans supporting global regulatory submissions.
Design and oversee clinical protocols, claims, and evidence strategies in collaboration with internal and external stakeholders.
Serve as a scientific liaison with regulatory authorities and mentor junior scientists to drive clinical excellence.
The company develops diagnostic products for the US and EU markets, focusing on generating robust clinical evidence for regulatory submissions. It maintains a remote-first culture with a collaborative, cross-functional environment and opportunities for scientific leadership.
Set clinical validation standards for new features, workflows, interventions, and AI-supported experiences before and after launch.
Bring the clinical lens to feature assessment alongside Product, calibrating the level of clinical rigor to the actual risk of each feature.
Monitor and interpret clinical outcomes to identify drivers of improvement, decline, or variation, and direct program, protocol, product, workflow, or training changes in response.
Sword is building AI to heal billions and unlock humanity’s full potential, pioneering a fundamentally new approach to healthcare called AI Care. Since 2020, Sword has expanded across multiple health areas, serving over 1 million members, 2,000+ enterprise clients, and backed by $500 million from leading investors.